title: Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient.
authors.forename: Roberto
authors.initials: R
authors.lastname: Littera
authors.forename: Marcella
authors.initials: M
authors.lastname: Arras
authors.forename: Antonio
authors.initials: A
authors.lastname: Ledda
authors.forename: Giovanni
authors.initials: G
authors.lastname: Caocci
authors.forename: Maria Bonaria
authors.initials: MB
authors.lastname: Tronci
authors.forename: Carlo
authors.initials: C
authors.lastname: Carcassi
authors.forename: Giorgio
authors.initials: G
authors.lastname: La Nasa
mesh_terms: D000328:Adult; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab; D065227:Transfusion Reaction; D017086:beta-Thalassemia / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab